Angel Investors and Venture Capitalists in the Alternative Medicine Market

There are 250+ alternative medicine investors in the Angel Match database, including angel investors, venture capitalists and private equity investors. Most are based in the United States, with the United Kingdom, Israel and the Netherlands next. Filter by location, stage or investor type to build a list that fits your startup.

Access investors in the alternative medicine sector

Last updated: October 1, 2026Author: Rashid Khasanov

125,000+ investors
297 investors
INVESTORLOCATIONINVESTOR TYPEMARKETSCONTACTSACTIONS
Investor Data Snapshot

Investor Data Snapshot

  • 250+

    Total investors

Top countries represented

United States, United Kingdom, Israel, The Netherlands, Belgium

Top states represented

California, England, New York, Texas, Massachusetts

Top cities represented

London, New York City, San Francisco, Los Angeles, Boston

Most common stages

Seed, early stage venture, pre-seed, Series A

Most common investor types

Private equity investors, venture capital, angel individual

Data reflects investors currently available in the AngelMatch database and updates regularly.

These numbers help founders understand the overall size and coverage of the investor database.

What the alternative medicine investor list looks like

Alternative medicine is a small, specialized tag. The 250+ investors on this page sit inside a database of 125,000+, a thin slice next to broad markets like health care and wellness, which each have tens of thousands of investors. That shape should change how you search. You won't find a deep bench of funds that only back alternative medicine. You'll find a smaller group that has shown interest in it, plus a much larger pool of health and wellness investors who might say yes if you frame your pitch the right way.

The mix of investor types is unusual for an early-stage list. Private equity investors are the biggest group here, venture capitalists are close behind, and angel investors make up roughly four in ten. Many people carry more than one type tag, so those groups overlap. Private equity investors usually back businesses that already have revenue, so if you're still pre-revenue, don't build your whole list around them. Angel checks usually land in the $25,000 to $500,000 range, which is a much better match for an early round.

Seed is the biggest stage group by a wide margin, at roughly a third of the page. Early stage venture comes next, while pre-seed, Series A, Series B and late stage trail far behind. Stage isn't filled in for every investor, so read those proportions as a guide, not a census. If you're raising at the pre-seed stage, that dedicated list is thin, which is one more reason to widen your search to seed investors and to the health and wellness pools above.

Where alternative medicine investors are based

Roughly six in ten of these investors are based in the United States. California leads the states, followed by England, New York, Texas and Massachusetts. The most common cities are London, New York City, San Francisco, Los Angeles and Boston, so the coasts and London do most of the work. Connecticut ranks sixth among states, ahead of Illinois, which most founders wouldn't guess.

The United Kingdom is the clear second market, and London is the single most common city on the whole list. Smaller countries punch above their weight, too. The Netherlands and Belgium each have more alternative medicine investors here than Canada does, and so does Singapore, a single city-state. Most of Israel's investors on this list sit in one city, Ra'anana, so that's one local cluster, not a national scene. If you're based in Europe or Asia, you don't have to assume the only real conversations happen in San Francisco.

Match your business model to the right investors

Alternative medicine covers a lot of ground, and investors judge each corner differently.

  • Product brands. Supplements, herbal products and functional foods get judged like consumer brands. Expect questions about margins, customer acquisition cost and repeat purchase, plus who makes the product and how it's tested.
  • Clinics and practitioner networks. Acupuncture, chiropractic and integrative care get judged like healthcare services. Expect questions about how many patients each practitioner sees, how you'd open a second location and who pays, patients or insurers.
  • Software and marketplaces. Booking tools, telehealth for complementary care and practitioner directories get judged like digital health startups. Those investors care most about growth and retention, and many of them won't carry an alternative medicine tag at all, so search terms like digital health too.

Don't trust the tag alone

Some profiles on this page list more than 50 markets. When someone tags that many, the alternative medicine label tells you they're open to the category, not that it's their focus. Before you add anyone to your outreach list, spend two minutes on their past investments. You want at least one company in health, wellness, supplements, clinics or consumer health. If you can't find one, treat them as a long shot and send a short, honest note instead of a long one that pretends to know their thesis.

A layered search saves time. Start with investors tagged to this market in your target country, then widen to health care and wellness, then cut the list down by stage. In the investor database you can combine market, stage and location filters in one search, so you can build each layer without starting over.

Why demand is real, and what investors still want to see

Demand is the easy part of your pitch. In the United States, the share of adults using at least one of seven complementary approaches (acupuncture, chiropractic care, guided imagery, massage, meditation, naturopathy and yoga) rose from 19.2% in 2002 to 36.7% in 2022, according to an NIH analysis of federal survey data. Abroad, the World Health Organization reported that 170 of its 194 member states, or 88%, acknowledged the use of traditional and complementary medicine as of 2018.

Investors already know the category is popular. What they want is proof that your company is more than a trend. In the same WHO report, the difficulty countries named most often in its 2012 survey was a lack of research data, ahead of a lack of research funding and weak safety monitoring. That's a good clue to the question you'll hear most: where's the evidence? If you have clinical data, a published study, a licensed practitioner on your team or repeat-purchase numbers, put them in your first two slides, not your appendix.

Get your claims right before you send a single email

If you sell a supplement, herbal product or wellness service in the US, your website copy is part of your pitch, and investors will read it. Under FDA rules, only a drug can legally claim to diagnose, treat, cure or prevent a disease, and supplement labels that make structure or function claims must carry a disclaimer saying so, according to the FDA's guidance on structure and function claims. A homepage that says your tincture "treats arthritis" is a red flag on first read. Rules differ in the UK, the Netherlands and other markets, so check each country you plan to sell in before it goes into a deck. Cleaning this up early is much cheaper than explaining it after an investor spots it.

How to approach alternative medicine investors

Open with the one number that shows people want what you sell: repeat orders, return patient visits, subscribers or revenue per clinic. Because the category is so popular, a lot of pitches lean on the trend, so a hard number in the first two lines of your email sets you apart. If you want a starting point, the free investor outreach email generator drafts a first version you can edit.

Match the ask to the investor's own profile. If they've backed a clinic business, talk about clinic economics. If they've backed consumer brands, talk about customer acquisition and repeat purchase. Mention a clinical advisor or licensed practitioner if you have one, since that answers a question many cautious investors will have.

Keep the round size honest, too. Angels typically write checks from $25,000 up to $500,000, while venture checks run from $2 million to $100 million or more, which is bigger than most early-stage companies in this space need. In an early round you'll usually give up around 15% to 25% of the company, so raise only what gets you to your next proof point.

Where to start

Start with the seed-stage investors tagged to alternative medicine in your home country, then add health care and wellness investors who've backed products like yours. Save your first twenty names and note which ones have real health portfolios and which are long shots. Tracking that, along with who opens and replies, in a fundraising CRM tells you quickly whether to narrow or widen the list.

Frequently Asked Questions

  • There are 250+ alternative medicine investors in the Angel Match database. Most are based in the United States, and the United Kingdom is a clear second.

  • Most alternative medicine investors in the database are based in the United States, roughly six in ten. California, England and New York have the most investors by state or region, and London, New York City and San Francisco are the most common cities.

  • Private equity investors, venture capitalists and angel investors all back alternative medicine startups. Private equity investors are the biggest group on this list, but many investors carry more than one type tag, so the groups overlap. Angel checks usually run $25,000 to $500,000, which suits the earliest rounds.

  • Seed is the most common stage, followed by early stage venture. Pre-seed, Series A, Series B and late stage investors are also on the list, but in much smaller groups, and stage isn't filled in for every investor.

  • It depends on the investor type. Angel checks usually run $25,000 to $500,000, and venture checks run from $2 million to $100 million or more. Early-stage founders usually start with angels or seed investors, since venture checks are sized for much bigger companies.

  • Yes, and the United Kingdom has the next largest group, followed by Israel, the Netherlands, Belgium, India and Singapore. Belgium, the Netherlands and Singapore each have more alternative medicine investors in the database than Canada does.

  • Not if it's a dietary supplement sold in the US. Under FDA rules, only a drug can legally claim to diagnose, treat, cure or prevent a disease, so keep disease claims out of your website, packaging and deck. Rules differ by country, and this isn't legal advice, so talk to a regulatory lawyer before you launch.

  • No, because the tag covers a small group and many investors with it list dozens of other markets. Widen your search to health care and wellness investors, then check each person's past investments for health-related companies before you reach out.

  • Yes. Investor profiles include contact details such as email addresses and LinkedIn profiles, and those unlock with a paid plan. Plans start at $59/month.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today